RLFTY

RELIEF THERAPEUTICS S/ADR by RELIEF THERAPEUTICS HLDG AG (RLFTY)

About RELIEF THERAPEUTICS S/ADR by RELIEF THERAPEUTICS HLDG AG (RLFTY)

RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.

Details

Daily high
$2.48
Daily low
$2.48
Price at open
$2.48
52 Week High
$5.05
52 Week Low
$1.40
Market cap
18.9M
Dividend yield
0.00%
Volume
1,031
Avg. volume
1,763
P/E ratio
-.96

RELIEF THERAPEUTICS S/ADR by RELIEF THERAPEUTICS HLDG AG News

Details

Daily high
$2.48
Daily low
$2.48
Price at open
$2.48
52 Week High
$5.05
52 Week Low
$1.40
Market cap
18.9M
Dividend yield
0.00%
Volume
1,031
Avg. volume
1,763
P/E ratio
-.96